DxS to Increase Research Capabilities with the Expansion of the Product Development Team
News Dec 10, 2008
DxS has announced the expansion of its Product Development Team in response to a marked rise in demand for its cancer diagnostics kits in 2008.
The Company has significantly increased its number of Research and Development staff in the final quarter of the year from four at the start of the year to eight, and plans to recruit a further five more Product Development Scientists in the next month.
The expansion of the Product Development team builds on DxS’ continued growth in 2008 which has so far seen DxS increase manufacturing capacity and acquire new premises in response to the increase in demand for its diagnostic and research mutation test kits.
David Whitcombe, Chief Scientific Officer at DxS said, “The quality and range of our products is centrally based upon the innovation and experience of our Development Team. Our scientists are dedicated to ensuring that we remain the market leaders in our field and lead the way in developing novel assays for the future”.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019